NMCAX
Price
$19.71
Change
-$0.21 (-1.05%)
Updated
Aug 29 closing price
Net Assets
715.09M
RPMGX
Price
$102.70
Change
-$0.49 (-0.47%)
Updated
Aug 29 closing price
Net Assets
27.31B
Interact to see
Advertisement

NMCAX vs RPMGX

Header iconNMCAX vs RPMGX Comparison
Open Charts NMCAX vs RPMGXBanner chart's image
Voya MidCap Opportunities A
Price$19.71
Change-$0.21 (-1.05%)
VolumeN/A
Net Assets715.09M
T. Rowe Price Mid-Cap Growth
Price$102.70
Change-$0.49 (-0.47%)
VolumeN/A
Net Assets27.31B
NMCAX vs RPMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NMCAX vs. RPMGX commentary
Sep 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCAX is a Hold and RPMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 27.3B vs. NMCAX (715M). NMCAX (0.00) and RPMGX (0.00) have matching dividends . NMCAX was incepted earlier than RPMGX: NMCAX (27 years) vs RPMGX (33 years). NMCAX (1.25) is less costly to investors than RPMGX (0.75). NMCAX is a more actively managed with annual turnover of: 87.00 vs. RPMGX (22.60). NMCAX has a lower initial minimum investment than RPMGX: NMCAX (1000) vs RPMGX (2500). NMCAX annual gain was more profitable for investors over the last year : 7.06 vs. RPMGX (-4.69). RPMGX return over 5 years is better than : 0.40 vs. NMCAX (-15.04).
NMCAXRPMGXNMCAX / RPMGX
Total Expense Ratio1.250.75167%
Annual Report Gross Expense Ratio1.250.75167%
Fund Existence27 years33 years-
Gain YTD8.2372.978277%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets715M27.3B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.06-4.69-151%
Returns for 3 years28.4011.83240%
Returns for 5 years-15.040.40-3,735%
Returns for 10 years-10.2133.56-30%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVM10.431.12
+12.03%
Cel-Sci Corp
NNNN45.043.57
+8.60%
Anbio Biotechnology
PNW89.360.04
+0.04%
Pinnacle West Capital Corp
UOKA2.56N/A
N/A
MDJM Ltd
SLDB5.48-0.14
-2.49%
Solid Biosciences